뉴스
- HLB Shares Plunge as AriBio Surges[K-Bio Pulse] South Korean pharmaceutical and biotechnology stocks diverged sharply on Nov. 4 despite gains in the HLB and its affiliates tumbled after a U.S. regulatory decision dashed hopes for a...
- 서학개미, 반도체주 투자 엇갈려…레버리지 ETF 매수세 stock settlement data via SEIBro for October 1–15 - Net sell-offs: $215.52 million in Micron and $95.01 million in SanDisk - Major tech stocks—including Tesla, Meta, and Nvidia—also saw a predominance of
- Daehwa, Dongkook Defy Market Slump…G2GBIO Falls More Than 10%[K-Bio Pulse] Pharmaceutical and biotech stocks diverged on company-specific developments as South Korean equities
- [Opening Market] KOSPI Opens Higher, Turns Soft As Samsung Earnings Beat Top automobile stocks Hyundai Motor and Kia are showing a slight downward trend of around 1,000 won..
- AriBio Holdings Hits Lower Limit After Scrapping Merger With AriBio [K-bio bulse] Korean pharmaceutical, biotech and healthcare stocks showed sharply mixed moves on Sept. 29 as company-specific
- KM Pharmaceutical Surges Despite Delisting; SK Biopharm Falls on FDA Hold [K-Bio Pulse] Korean pharmaceutical and biotech stocks showed mixed performances on Sept. 11, with KM Pharmaceutical and BL Pharmtech both hitting their daily upper price limits.
- JW Pharma Jumps 15%, OliX Sinks 14% on Overhang Concerns[K-Bio Pulse] South Korean pharmaceutical and biotech stocks broadly traded lower, with JW Pharmaceutical and OliX
- Broker Call Lifts Qurient, AbClon, L&C Bio Rebounds on Rights Offering[K-Bio Pulse] South Korea's Kosdaq market closed higher on Tuesday, supported by net buying from foreign and institutional investors, while most pharmaceutical and biotechnology stocks also gained.
- Biotech Stocks Rally with Market Rebound; Orum Therapeutics Jumps 18% [K-Bio Pulse] On July 31, South Korean pharmaceutical and biotech stocks broadly advanced as domestic equities rebounded , with bargain hunting returning to beaten-down growth and biotech names.
- FromBio Hits Limit-Up as Trading Resumes; Curacle Surges on Follow-On Licensing Hopes [K-Bio Puls... On Aug. 10, South Korean pharmaceutical and biotech stocks broadly advanced as the KOSDAQ rebounded.
1 페이지
다음 →